Investor
The long-term strategic partnership between Ada Health and Bayer will empower individuals to take greater ownership of their personal health and make informed decisions.
The pharma giant’s Digital Health Partnership Program welcomes new innovators in mental health, women’s health and more.
The life science company plans to launch its open research tool in 2022.
New NHS platform launched to address mental health crisis in young people.
The company is set to debut in the KOSDAQ early next year.
Lindera’s ‘SturzApp’ facilitates motion analysis via an app, using smartphone or tablet cameras to track movement and reduce the risk of falls in seniors.
Polish-based Docplanner steps up expansion plans in Germany.
The firm plans to further develop its blood typing technology.
The Series C brings its total raise to $160 million.
Funding will help take its DTx solutions through regulatory approvals and to market in the UK and US.